DNA nanotechnology produces precision nanostructures of defined chemistry. Expanding their use in biomedicine requires designed biomolecular interaction and function. Of topical interest are DNA nanostructures that function as vaccines with potential advantages over non-structured nucleic acids in terms of serum stability and selective interaction with primary human immune cells. Here we describe how compact DNA nanobarrels bind with a 400-fold selectivity via membrane anchors to white blood immune cells over erythrocytes, without affecting cell viability.The selectivity is based on the preference of the cholesterol lipid anchor for the more fluid immune cell membranes compared to the lower membrane fluidity of erythrocytes. Compacting DNA into the nanostructures also gives rise to increased serum stability. The DNA barrels furthermore functionally modulate white blood cells by suppressing the immune response to pro-inflammatory endotoxin lipopolysaccharide. This is likely due to electrostatic or steric blocking of toll-like receptors on white blood cells. Our findings on immune-cell specific DNA nanostructures may be applied for vaccine development, immunomodulatory therapy to suppress septic shock, or the targeting of bioactive substances to immune cells. KEYWORDS DNA; DNA nanotechnology, bilayer membrane, white blood cells, lipids, immunomodulation, nanostructures ToC GRAPHIC 3 DNA nanostructures advance nanotechnology and the life sciences. Compared to other materials, DNA nanostructures have an unsurpassed highly controllable architecture which is based on predictable folding using base-pairing rules. [1][2][3][4][5] By exploiting these properties, the functional structures are increasingly designed to benefit areas outside DNA nanotechnology. Examples include DNA scaffolds which precisely position proteins and other biomolecular components for biophysical and molecular biological research, [1][2][6][7][8] or as scaffold to organize enzymes into efficient multistep biocatysts. 9 Furthermore, predictable changes in DNA nanostructures have been exploited for smart biosensing 10 to measure pH inside cells [10][11][12] or to delivery bioactive cargo into cells. 13 The greatest reward is expected in biomedicine [14][15][16] as illustrated by a DNA nanorobot to deliver anti-cancer drugs 17 or larger nanostructures that mitigate acute kidney injury within animal models. [18][19] Immunology and vaccine development are of topical interests for DNA nanotechnology. Nonstructured DNA and RNA have previously been developed into vaccines against cancer. [20][21][22][23] The relevance of nucleic acids-based therapy platforms has been further increased with the SARS-CoV-2 pandemic. 24-29 A main advantage of mRNA type vaccines is the speed at which they can be developed and manufactured compared to traditional protein-based vaccines. Nevertheless, DNA and RNA vaccines have disadvantages including their low potency, poor uptake into immune cells, lack of stability against nucleases, and fast clearance rates. 20,30-31 These la...